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Summary
Background
The development of classification methods for personalized medicine is highly dependent on the
identification of predictive genetic markers. In survival analysis it is often necessary to discrimi-
nate between influential and non-influential markers. Usually, the first step is to perform a uni-
variate screening step that ranks the markers according to their associations with the outcome.
It is common to perform screening using Cox scores, which quantify the associations between
survival and each of the markers individually. Since Cox scores do not account for dependencies
between the markers, their use is suboptimal in the presence highly correlated markers.
Methods
As an alternative to the Cox score, we propose the correlation-adjusted regression survival
(CARS) score for right-censored survival outcomes. By removing the correlations between the
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markers, the CARS score quantifies the associations between the outcome and the set of “de-
correlated” marker values. Estimation of the scores is based on inverse probability weighting,
which is applied to log-transformed event times. For high-dimensional data, estimation is based
on shrinkage techniques.
Results
The consistency of the CARS score is proven under mild regularity conditions. In simulations,
survival models based on CARS score rankings achieved higher areas under the precision-recall
curve than competing methods. Two example applications on prostate and breast cancer con-
firmed these results. CARS scores are implemented in the R package carSurv.
Conclusions
In research applications involving high-dimensional genetic data, the use of CARS scores for
marker selection is a favorable alternative to Cox scores even when correlations between covari-
ates are low. Having a straightforward interpretation and low computational requirements, CARS
scores are an easy-to-use screening tool in personalized medicine research.
Key words: Biomarker discovery; Breast cancer; Multi-gene signature; Personalized medicine; Prostate
cancer; Survival modeling
1. Introduction
One of the key issues in personalized medicine is to identify genetic marker signatures for the
planning and the prognosis of targeted cancer therapies. With more than one of three people de-
veloping some form of cancer during their lifetimes (Howlader and others, 2016), individualized
therapies based on genetic markers are expected to play a major role in improving progression-free
and overall survival of cancer patients. Among men, for example, prostate cancer is the cancer
with the highest prevalance. While there are several clinical models available for predicting disease
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progression, it remains a challenging task to develop molecular signatures and improve predictive
accuracy of existing models (Sboner and others, 2010).
Since cancer research is heavily focused on time-to-event outcomes such as progression-free
survival, metastasis-free survival and/or overall survival, survival analysis is one of the predom-
inant statistical approaches to analyze data collected in clinical cancer trials. When the aim
is to relate a time-to-event outcome to a set of predictors (e.g., clinical information or genetic
markers), it is common to use a survival model such as the proportional hazards model by Cox.
However, when data are high-dimensional (e.g., when the number of measured genetic markers
exceeds the sample size), it is impossible to fit a Cox regression model including all available co-
variates. A solution to this problem could be to use regularized methods such as ridge-penalized
Cox regression, but even these methods often break down when the number of available markers
(in particular, the number of non-influential markers) is large. Is therefore common practice to
carry out data-driven variable selection before fitting the survival model, and to include only
those “influential markers” that have passed selection step.
The predominant method for variable selection in cancer research is univariate screening,
which evaluates the associations between the outcome of a trial and each covariate separately,
e.g., by computing correlation coefficients or fitting simple regression models. The coefficients of
association are usually ranked by magnitude, and the most highly ranked covariates are selected
for inclusion in the statistical model of interest. Fan and Lv (2008) have provided a theoretical
justification for this approach by showing that univariate screening is suitable to identify influ-
ential covariates with high probabilities under mild regularity conditions. Still, a major problem
of this approach is that associations between covariates are ignored, and that the set of selected
markers may include many redundant markers if these are highly correlated (and hence carry
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the same information regarding their associations with the outcome). While decreasing the ro-
bustness of the final statistical model, a large set of redundant markers will also cause influential
markers with weaker univariate associations to be dropped from the model. This information loss
is particularly problematic when the number of selected markers needs to be restricted to a small
value due to sample size or cost limitations.
In survival analysis with a right-censored time-to-event outcome, univariate screening is mostly
done by computing Cox scores, which are given by either the Z scores obtained from univariate
Cox regression models or by the p-values obtained from the respective likelihood ratio or score
tests. Although p-values can be corrected for multiple testing (e.g. see Benjamini and Hochberg
(1995)) to identify informative covariates, Cox scores share the same disadvantages as the uni-
variate screening methods mentioned above.
To address these problems, we consider the correlation-adjusted regression (CAR) score ap-
proach, which provides a criterion for variable ranking that is based on the de-correlation of
covariates in linear regression. By applying a Mahalanobis-type “de-correlating” transformation
to the covariates, CAR scores measure the correlations between the de-correlated variables and
the continuous outcome. The set of correlation coefficients defines a ranking of the covariates,
which can be used to select informative variables in the same way as with the univariate screen-
ing methods described above. As the correlation coefficients among the covariates tend to zero,
CAR scores become identical to the correlations between the non-transformed covariates and the
outcome. In simulations for linear regression, CAR scores were shown to outperform methods
for regularized regression (boosting, lasso) with regard to their ability to correctly recover causal
genetic markers and their rankings (Zuber and others, 2012). On the other hand, CAR scores
have not been used to model time-to-event outcomes in cancer research, as an extension of the
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CAR approach to right-censored data has been lacking so far.
The purpose of this paper is therefore to develop a CAR-based method for ranking high-
dimensional sets of genetic marker variables in survival analysis. The resulting score, which in
the following will be termed correlation-adjusted regression survival (CARS) score, quantifies the
correlations between the log-transformed survival time Y = log(T ) and the de-correlated set of
covariates X. We will first define a theoretical version of the CARS score on the population level
(Section 2.1). Afterwards, we will provide details on the estimation of the scores from a sample
of right-censored data (Section 2.2). Specifically, we will show that all relevant expressions can
be estimated using inverse-probability-of-censoring (IPC) weighting techniques, as proposed by
Van der Laan and Robins (2003). In Section 3, we will present the results of a simulation study
that was carried out to compare the CARS approach to univariate screening based on Cox scores.
In addition, we will apply CARS scores to the Swedish Watchful Waiting Cohort data (Sboner
and others, 2010) and to a data set on invasive breast cancer (Hatzis and others, 2011). The
results of the paper will be summarized in Section 4.
2. Methods
2.1 Full data world / population level
The main focus of survival modeling is on analyzing the effects of a set of covariates x ∈ Rd
on a survival time T ∈ R+. We assume that the vector x = (X1, . . . , Xd)> has expectation µ,
covariance matrix Σ and correlation matrix PX . Similarly, we assume that the survival time T
has a finite expectation µT and variance σ
2
T . A popular approach to quantify the relationship
between T and x is the parametric accelerated failure time (AFT) model (Klein and others,
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2013), which is based on log-transformed survival time Y := log(T ) and the model equation
Y = β0 + x
Tβ +  , (2.1)
where β ∈ Rd is a vector of regression coefficients and  a noise variable. For the derivation
of CARS scores we will consider the special case of log-normally distributed survival times, i.e.
 is assumed to follow a normal distribution with zero mean and constant variance. Then the
expected squared prediction error E
(
(Y − β0 − xTβ)2
)
is minimized by regression coefficients
equal to
β∗ = Σ−1ΣXY , (2.2)
where ΣXY is the d-dimensional vector of covariances between x and Y , and the intercept
β∗0 = µY − βTµ . (2.3)
Model (2.1) is a Gaussian linear regression model. Therefore, in the absence of censoring, a
measure of variable importance is the CAR score θ (Zuber and Strimmer, 2011) defined by
θ = P
−1/2
X PX,Y , (2.4)
where PX ∈ Rd×d is the correlation matrix of the covariates X and PX,Y ∈ Rd×1 is the vector of
correlations between the covariates X and the log-transformed survival time Y = log(T ). Anal-
ogous to Cox scores, the components of θ can be ordered by magnitude to give an importance
ranking of the covariates.
The original CAR score for Gaussian linear regression can be interpreted as the correlations
between the outcome variable and the de-correlated covariates, which are defined by the orthog-
onal transformation z = P
−1/2
X x (Zuber and Strimmer, 2011). Using the best linear unbiased
predictor Y ? = β∗0 + x
Tβ∗ derived from Estimators (2.2) and (2.3), and defining σ2Y := Var(Y ),
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the total variance of Y can be decomposed as follows:
Total variance︷ ︸︸ ︷
Var(Y ) =
Explained variance︷ ︸︸ ︷
Var(Y ?) +
Unexplained variance︷ ︸︸ ︷
Var(Y − Y ?) (2.5)
= σ2Y P
2
Y,Y ∗ + σ
2
Y (1− P 2Y,Y ∗) , (2.6)
where
P 2Y,Y ∗ = P
>
X,Y P
−1
X PX,Y = θ
Tθ (2.7)
is the squared correlation between Y and Y ∗. From Equations (2.5) to (2.7) it follows that the
CAR score is the central quantity to assess which variables contribute to the explained variance,
or equivalently reduce the unexplained variance. Importantly, P
−1/2
X x is not the Mahalanobis
transform but another form of de-correlation that has the advantageous feature of maximiz-
ing the correlation between the de-correlated covariates and the standardized original covariates
(Kessy and others, 2016). In contrast, the Mahalanobis transform maximizes the cross-covariance
between the de-correlated covariates and the original covariates. Zuber and Strimmer (2011) and
Zuber and others (2012) demonstrated that estimated CAR scores result in improved variable
rankings and a high predictive performance when compared to other variable selection and model-
ing techniques such as lasso or boosting. Although these estimated scores work well for regression
models with a continuous outcome, they were not able to deal with right-censored data so far.
We will therefore develop the CAR survival (CARS) score that extends traditional estimators of
CAR scores to survival modeling.
2.2 Observed data world / sample level
In the observed data world one often has to deal with right-censoring, i.e. one is no longer able
to observe the uncensored survival times of all observations but only the minimum of the true
survival time T and a censoring time C ∈ R+. The observed variable of interest is then defined by
Y˜ = log(T˜ ), where T˜ := min(T,C). Additionally, we introduce a status indicator ∆ := I(T 6 C),
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i.e., ∆ = 1 if the event is observed and ∆ = 0 if censoring has occurred. We will further assume
that T and C are independent random variables. At the sample level the empirical CAR score is
defined by
θˆ = R
−1/2
shrinkRX,Y , (2.8)
where Rshrink ∈ Rd×d is a shrinkage estimator of the correlation matrix PX and RX,Y ∈ Rd×1
is an estimator of the vector of correlations PX,Y . The definition of Rshrink will be provided
below. In contrast to uncensored Gaussian regression, standard estimation of PX,Y using the
sample correlations between x and Y˜ is no longer appropriate, as this would result in biased
estimators in the presence of right-censoring. To overcome this problem, we suggest to adjust
the sample correlations by inverse-probability-of-censoring (IPC) weighting (Van der Laan and
Robins, 2003), which will result in a consistent estimator of PX,Y .
Definition of IPC weigths for right-censored data: Let T˜1, . . . , T˜n be the observed values of
T˜ and C1, . . . , Cn the underlying censoring times in a sample of i.i.d. observations of size n.
Following Van der Laan and Robins (2003), we define the IPC weight of the i-th observation by
wi :=
∆i
Gˆn(log(T˜i))
, i ∈ {1, . . . , n} , (2.9)
where ∆i, i = 1, . . . , n, are the sample values of ∆ and Gˆn(log(T˜i)) is an estimate of the survivor
function G(log(Ti)) of the logarithmic censoring process, i.e. the probability
G(log(T˜i)) = P (log(Ci) > log(T˜i)) . (2.10)
By definition, censored observations (∆i = 0) result in zero IPC weights. In line with Van der
Laan and Robins (2003), we further assume that G(·) > ν > 0, where ν is a small positive real
number (this assumption will become important in the consistency proof in Appendix A.1). To
compute Gˆn(·), we apply the Kaplan-Meier estimator to the observed logarithmic survival times
High dimensional CARS 9
T˜1, . . . , T˜n, using the event indicators 1−∆i, i = 1, . . . , n.
Estimation of the correlation vector PX,Y using IPC weighting: The estimation of PX,Y
comprises of the following steps:
1. Estimate the expectations of the covariates X1, . . . , Xd by their empirical means X¯j =∑n
i=1Xij/n, j = 1, . . . , d, respectively, where Xij denotes the sample value of the j-th
covariate in observation i. Similarly, estimate the variances of X1, . . . , Xd by their sample
variances S2j =
∑n
i=1
(
Xij − X¯j
)2
/(n− 1), j = 1, . . . , d.
2. Estimate the expectation of Y by the weighted mean
Y¯w =
1
n
n∑
i=1
wi log(T˜i) , (2.11)
where wi , i = 1, . . . , n are the IPC weights defined in Equation (2.9). Similarly, estimate
the variance of Y by
S2Y ;w =
1
n
n∑
i=1
wi
(
log(T˜i)− Y¯w
)2
. (2.12)
3. The covariance of Xj and Y is again estimated by IPC weighting:
SXj ,Y ;w =
1
n
n∑
i=1
wi(Xij − X¯j)
(
log(T˜i)− Y¯w
)
, j = 1, . . . , d. (2.13)
4. The final step is to compute the empirical correlation vector RX,Y by combining the esti-
mators defined in Steps 1 to 3 above:
RX,Y =
 SXj ,Y ;w√
S2Xj
√
S2Y ;w

j=1,...,d
. (2.14)
Estimation of the correlation matrix P
−1/2
X : Since the data values of the covariates are not
affected by censoring, the usual sample variance-covariance estimators could be applied to obtain
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an estimate of P
−1/2
X . In the presence of high-dimensional data, however, these estimators usually
break down. For example, the estimation of the d× d correlation matrix PX – or more precisely
its inverse square root – is challenging when when d is much larger than the sample size (Edgar
and others, 2002; Kolesnikov and others, 2014). We therefore propose to employ a shrinkage
correlation estimator (Scha¨fer and Strimmer, 2005; Zuber and Strimmer, 2011) to estimate PX ,
which is given by
Rshrink = λId + (1− λ)RX , (2.15)
where λ ∈ R+ is a shrinkage parameter, Id is the identity matrix of dimension d × d, and RX
is the matrix containing the empirical bivariate sample correlations of the covariates. Following
Scha¨fer and Strimmer (2005), we define λ :=
∑
j 6=k V̂ar(rj,k)/
∑
j 6=k r
2
j,k, where rj,k denotes the
sample correlation between the j-th and the k-th covariate. The inverse square root R
−1/2
shrink can
be computed very efficiently by applying a singular value decomposition of the sample correlation
matrix. For details, we refer to Zuber and Strimmer (2011) and Kessy and others (2016). The
estimation of PX,Y described above, combined with the shrinkage estimator Rshrink, defines the
CARS score in Equation (2.8).
Consistency of CARS scores: Next we give a sketch of the consistency proof for the estimated
CARS score θˆ = R
−1/2
shrinkRX,Y . As shown in detail in Appendix A.4, θˆ converges to its popula-
tion value θ = P
−1/2
X PX,Y as n→∞, provided that (i) censoring is independent of the survival
times, and (ii) the Kaplan-Meier estimator Gˆn is a consistent estimator of G. More specifically,
by embedding the IPC-weighted expressions given in the Estimators (2.11) to (2.14) in the frame-
work of unbiased estimating equations (Huber, 1967; Carroll and Ruppert, 1988), we show that
each of the estimators contained in the definition of θˆ is a consistent estimator of its respective
population variance or covariance. As a consequence, θˆ results in a consistent estimator of the
population value θ.
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Variable selection based on CARS scores: As shown above, CARS scores measure the associ-
ations between the de-correlated covariates and the time-to-event outcome T . Variable selection
can therefore be carried out by ranking the CARS scores according to their absolute values. A set
of covariates is selected whose absolute CARS scores exceed the pre-defined threshold value φ.
A suitable threshold can, for example, be obtained by cross-validating the multivariable survival
model that incorporates the selected covariates. In this paper, we will use a computationally
less expensive strategy and apply the adaptive false discovery rate density approach proposed by
Strimmer (2008), which assumes a two-component discrete mixture model of “influential” and
“non-influential” covariates. Based on this model, a suitable threshold value φ can be estimated
by a tradeoff between the false-non-discovery rate P (“influential”|θ 6 φ) and the false-discovery
rate P (“not-influential”|θ > φ). The associated parameters of the mixture model are estimated by
penalized maximum likelhood and a modified semi-parametric Grenander estimator (Grenander,
1956; Strimmer, 2008). For details, and also for an overview of the advantages of the approach,
we refer to Strimmer (2008).
3. Results
3.1 Design of the simulation study
To analyze the performance of CARS scores, we compared the CARS-based screening approach to
a univariate screening approach using Cox scores (Fan and Lv, 2008). With the latter approach,
a univariate Cox model was fitted for each covariate, and the Cox scores were given by the stan-
dardized coefficients of these models. In addition, we fitted multivariable Cox regression models
with L1-penalized coefficients (Simon and others, 2011). In these models, a variable was consid-
ered to be “included” in the model when its L1-penalized coefficient estimate differed from zero.
To ensure a fair comparison with the other methods, no tuning of the regularization parameter
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was applied, as this would have required additional test data. Instead we used the median value
of the default L1 norm regularization path computed by the R (R Core Team, 2017) package
glmnet (Simon and others, 2011).
We considered three sample sizes (n ∈ {250, 500, 1000}) and three dimensions of the covariate
space (d ∈ {500, 1000, 2000}). The covariate values were generated from a multivariate normal
distribution with zero mean. For the covariance structure of the multivariate normal distribution,
a block correlation structure with three equally sized blocks was constructed. In the first block,
50% of the correlations were set to ρ = −0.25, and the other 50% were set to ρ = 0.25. In the
second block, 50% of the correlations were set to ρ = 0.5 and the other 50% to ρ = −0.5, and in
the third block, 50% of the correlations were set to ρ = 0.75 and the other 50% to ρ = −0.75. The
correlation between covariates belonging to different blocks was zero. To satisfy the restrictions
of a correlation matrix (e.g. positive definiteness) the closest correlation matrix with regard to
quadratic elementwise differences was computed. Further details on the algorithm for the con-
struction of the correlation matrix are given in the Appendix B.4.
The percentages of influential covariates that were related to the time-to-event outcome was
varied according to the values 1%, 5%, and 10%. Two different correlation scenarios were ana-
lyzed: In the first scenario all influential variables were taken from the first block of the correlation
matrix (“scenario with low absolute correlations”), and in the second scenario all influential vari-
ables were taken from the third block (“scenario with high absolute correlations”). The survival
process was assumed to follow a log-normal distribution T ∼ logN(logµT , log σ2T ) with expecta-
tion logµT = Xβ. The coefficients β were specified to be equidistant within the interval [−0.9, 1],
depending on the number of influential covariates. The variance log σ2T was adjusted such that
explained variances of {25%, 50%, 75%} were achieved on the log-scale. The censoring process was
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also assumed to be log-normally distributed. Its parameters were adjusted such that censoring
rates of 0.25 and 0.75 were obtained. All values of the observed times that were higher than their
empirical 90% quantile were cut off and were set to be censored. For each of the scenarios we
carried out 300 independent simulation runs.
To evaluate the performance of the methods, the covariates selected by CARS scores, Cox
scores and L1 penalized Cox regression were compared to the sets of influential variables having
a true (non-zero) effect on the survival times. For each threshold of the CARS and Cox scores,
these comparisons resulted the cross-tabulation of the binary variables “selected vs. non-selected”
and “influential vs. non-influential”. In the case of L1 penalized Cox regression variables with
coefficients greater than zero were defined as selected and all other variables as non-selected.
Since we were interested in detecting a small set of influential markers within a sparse modeling
framework, we used the area under the precision-recall curve (PR-AUC, Rijsbergen 1979) to
evaluate the cross tables and to measure the performance of the three methods. In addition, we
investigated the ability of the methods to rank the variables - from least to most important -
by analyzing the rank correlations between the true absolute coefficients and the corresponding
estimated absolute CARS or Cox scores.
3.2 Scenario with low absolute correlations and low censoring rate
The results of the scenario with low absolute correlations (first block of the correlation matrix,
ρ = ±0.25) and with 25% censoring rate are presented in this section. After running the algorithm
for the construction of the correlation matrix (presented in Appendix B.4), all correlations had
absolute values that were smaller than 0.3. Figure 1 shows the summary of all simulations results
regarding sample size n and number of covariates d. The median of CARS scores was higher
than both Cox score approaches in most combinations of n and d. In addition Figure 2 displays
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Fig. 1. Simulation: PR-AUC of CARS, Cox and Cox L1 scores stratified by sample size (n) and number
of covariates (d) with low absolute covariate correlations (ρ = ±0.25) and low censoring rate of 25%.
Each boxplot summarizes the results of 2700 simulation runs (3 explained variance ratios x 3 signal to
noise ratios x 300 repetitions).
the results with respect to the relative number of influential variables (relVar) and the explained
variance (expVar). In most cases CARS scores had again higher median PR-AUC performance,
except for the two upper right cases relVar = 0.01 with expVar = 0.5 or expVar = 0.75. Higher
signal to noise ratios increased the performance of CARS on average. The PR-AUC of CARS
scores had the largest variability compared to the Cox approaches. L1 penalized Cox scores
showed larger variability of PR-AUC than Cox scores. Further CARS scores ranked influential
variables better in the median than Cox scores, as shown in Figure 3. An overall summary is
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Fig. 2. Simulation: PR-AUC of CARS, Cox and Cox L1 scores stratified by relative number of relevant
variables (relVar) and explained variance (expVar) with low absolute covariate correlations (ρ = ±0.25)
and censoring rate of 25%. Each boxplot summarizes the results of 2700 simulation runs (3 sample sizes
x 3 number of covariates x 300 repetitions).
available in Figure 13 in the appendix.
16 Welchowski, T. and Zuber, V. and Schmid, M.
−0.4
−0.3
−0.2
−0.1
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
CARS Cox
Method
Sp
ea
rm
a
n
 C
or
re
la
tio
n
Fig. 3. Simulation study – scenario with low absolute correlations (ρ = ±0.25): This boxplot visualizes the
rank correlations of the estimated and the true covariate orderings, as obtained from variable selection
by CARS scores, Cox scores and L1-penalized Cox regression. The censoring rate was equal to 25% and
low absolute covariate correlations ρ = ±0.25. Each boxplot shows the results of 24300 simulation runs
(3 explained variance ratios x 3 signal to noise ratios x 3 sample sizes x 3 number of covariates x 300
repetitions).
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3.3 Scenario with high absolute correlations and low censoring rate
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Fig. 4. Simulation: PR-AUC of CARS, Cox and Cox L1 scores stratified by sample size (n) and number
of covariates (d) with high absolute covariate correlations ρ = ±0.75 and censoring rate of 25%. Each
boxplot shows the results of 2700 simulation runs (3 explained variance ratios x 3 signal to noise ratios
x 300 repetitions).
Figure 4 presents the results of the scenario with high absolute correlations (third block of
the correlation matrix, ρ = ±0.75) and with a censoring rate of 25% regarding sample size
n and number of covariates d. The median of CARS scores was higher than both Cox score
approaches for most combinations of n and d. However the PR-AUC performance of Cox scores
decreased in comparison to the low correlation ρ = 0.25 scenario. Figure 5 displays the results
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Fig. 5. Simulation: PR-AUC of CARS, Cox and Cox L1 scores stratified by relative number of relevant
variables (relVar) and explained variance (expVar) with high absolute covariate correlations ρ = ±0.75
and censoring rate of 25%. Each boxplot shows the results of 2700 simulation runs (3 sample sizes x 3
number of covariates x 300 repetitions).
with respect to the number of influential variables and the explained variances. If relVar > 0.05
CARS scores had again higher median PR-AUC performance than both Cox score approaches.
The lack of adjustment for between-covariate correlations degraded performance of Cox scores.
This effect propagated to the rank correlation (Figure 6); in particular, the gap between median
rank correlations of CARS and Cox scores had become larger compared to the low correlation
scenario (Figure 3). The Figure 4 in the appendix shows a summary of all simulations results.
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Fig. 6. Simulation study – scenario with high absolute correlations (ρ = ±0.75): The boxplots visualize
the rank correlations of the estimated and the true covariate orderings, as obtained from variable selection
by CARS scores, Cox scores and L1-penalized Cox regression. The censoring rate was equal to 25% and
high absolute covariate correlations ρ = ±0.75. Each boxplot shows the results of 24300 simulation runs
(3 explained variance ratios x 3 signal to noise ratios x 3 sample sizes x 3 number of covariates x 300
repetitions).
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3.4 Scenario with high absolute correlations and high censoring rate
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Fig. 7. Simulation: PR-AUC of all methods stratified by sample size (n) and number of covariates (d)
with high absolute covariate correlations of ρ = ±0.75 and censoring rate of 75%. Each boxplot shows the
results of 2700 simulation runs (3 explained variance ratios x 3 signal to noise ratios x 300 repetitions).
In this section the results of the scenario with high absolute correlations (third block of the
correlation matrix, ρ = ±0.75) and with a high censoring rate of 75% are analyzed. This case
is particularly challenging, as approximately 75% of the IPC weights become zero, implying
that CARS scores were essentially computed from only 25% of the observations. Consider, for
example, the cases n <= d in Figure 7, where the PR-AUC performance of all methods was
nearly random. If sample size increased above the number of covariates n > d the CARS score
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Fig. 8. Simulation: PR-AUC of CARS, Cox and Cox L1 scores stratified by relative number of relevant
variables (relVar) and explained variance (expVar) with high absolute covariate correlations of 0.75 and
censoring rate of 25%. Each boxplot shows the results of 2700 simulation runs (3 sample sizes x 3 number
of covariates x 300 repetitions).
median PR-AUC performance grew higher than the Cox approaches compared to the scenarios
n <= d. Increasing the number of influential covariates relVaR = 0.01 to relVar = 0.1 yielded
better CARS score PR-AUC performance. Especially in cases relVar = 0.1 and explained variance
expVar >= 0.5 CARS scores achieved better median results than Cox approaches. Regarding rank
correlations both CARS and Cox approaches behaved similiar as in the previous scenario with
high correlations of ρ = ±0.75 and low censoring rate of 25% (Figure 9). The overall summaries
with different correlation and censoring structrues, averaged over all design parameters, are given
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in the Appendix B.3. In the case with low censoring rates of 25% CARS scores performed better
than Cox approaches. High censoring rates of 75% and high absolute covariate correlations of
ρ = ±0.75 CARS scores and Cox scores with L1 penalty were competitive, but without penalty
Cox scores were below the PR-AUC of a random classifier.
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Fig. 9. Simulation study – scenario with high absolute correlations (ρ = ±0.75) and a high censoring rate
of 75%: The boxplots visualize the rank correlations of the estimated and the true covariate orderings,
as obtained from variable selection by CARS and Cox scores. Each boxplot shows the results of 24300
simulation runs (3 explained variance ratios x 3 signal to noise ratios x 3 sample sizes x 3 number of
covariates x 300 repetitions).
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3.5 Runtime in the low correlation, low censoring scenario
Besides the predictive performance the computational efficiency of the statistical methods is
relevant in the analysis of high-dimensional genomic data. Therefore we additionally measured
the computation of CARS, Cox and Cox L1 scores without threshold models in the baseline
scenario with low covariate correlations ρ = ±0.25 and low censoring rate 0.25. All run times
were recorded without parallelization on the same computer with a processor Intel(R) Core(TM)
i7-7700 CPU @ 4.20 Ghz and 16 GB RAM in R statistical software. CARS scores were computed
by using R package carSurv. Cox scores were calculated by R packages survival and glmnet. Figure
10 shows that CARS scores are on average faster to compute than Cox scores with or without
L1 penalty for scenarios n < 1000. Especially in high dimensional context with low number of
observations the magnitude between the run times of CARS compared to Cox approaches was
large. In scenario n = 1000, d = 500 CARS and Cox approaches yielded comparable runtimes
and in the cases n = 1000, d > 500 Cox approaches performed faster.
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Fig. 10. Computational efficiency: Log-transformed time of the three methods CARS, Cox scores and Cox
L1 variable selection. The original time was measured in seconds without parallelization. Each boxplot
shows the results of 2700 simulation runs (3 explained variance ratios x 3 signal to noise ratios x 300
repetitions).
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3.6 Application to the Swedish Watchful Waiting Cohort
To investigate the properties of the proposed screening method in a real-world setting, we ap-
plied the CARS score to the Swedish Watchful Waiting Cohort data (Sboner and others, 2010).
The data consists of 281 patients and 6157 variables. Beside the clinical covariates (such as pa-
tient age, Gleason score and year of diagnosis) an array of 6100 gene expression profiles (6K
DASL) was designed by using four complementary DNA (cDNA)-mediated annealing, selection,
ligation, and extension (DASL) assay panels (DAPs) (Fan and others, 2004; Bibikova and oth-
ers, 2004). Further details of this procedure are available at GeneExpression Omnibus (GEO:
http://www.ncbi.nlm.nih.gov/geo/) with platform accession number GPL5474. The data is also
available at the GEO website with accession number GSE16560.
The study population included men who died from prostate cancer during follow up or sur-
vived at least 10 years after their diagnosis. The sample size was further restricted to men with
high-density tumor regions and who did not receive any type of androgen deprivation. The event
of interest was death of prostate cancer; 26.69% of the patients were censored. The median ob-
served time was 100 months (range [6, 274] months). The median age was 74 years (range [51, 91]
years), the median Gleason score was seven (range [2, 10]), and 58.72% of patients had a lethal
diagnosis. The 2.5% and 97.5% quantiles of the Pearson correlations between the gene expres-
sions were [−0.2634, 0.2865] and the maximum absolute correlation was 0.9861. Therefore most
genes were similar to the low correlation used in the simulation design (Section 3.1), in which
CARS scores yielded favorable PR-AUC results. We applied CARS scores to screen for genes that
influenced time to death of patients and evaluated their performance in comparison to Cox scores.
As the true effects of the genetic markers were unknown, it was not possible to analyze CARS
and Cox scores by using the PR-AUC and rank correlation techniques considered in the previous
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subsections. Instead, we evaluated the scores by comparing their ten times repeated ten-fold-
cross-validated predictive performance. The latter was measured by the time-dependent PR-AUC
(Yuan and others, 2016), which is an extension of PR-AUC to censored data by applying inverse
probability weighting (Van der Laan and Robins, 2003). The time-dependent PR-AUC can be in-
terpreted as average positive predictive value. In addition, we computed a time-independent sum-
mary performance measure by weighting and integrating PR-AUC over time (”time-integrated
PR-AUC”, see Equation A.10 in Appendix A). In each of the 10×10 training folds CARS and Cox
scores were estimated. Each set of risk score values was split into influential and non-influential
genetic markers with a predefined q-value cut-off threshold α1 ∈ {0.01, 0.05, 0.1}. The cut-off
threshold was compared to the q-values given by the method of Strimmer (2008) described in
Section 2. For the Cox scores we used the same threshold procedure as CARS scores. All genetic
markers with lower q-values than the specified threshold were selected and incorporated into a
multivariable Cox regression model. Afterwards, the selected genetic markers were incorporated
in a multivariable Cox regression model that also included a clinical baseline formula with the
variables age, Gleason score and extremity diagnosis (patient group lethal or indolent) (Sboner
and others, 2010). The performance of a random classifier corresponds to the time integrated
event rate, which was calculated as the time-dependent event rate P (T < t0) averaged over all
available time points t0 within one fold. The average of the time integrated event rates was com-
puted over 10× 10 cross validation folds.
Time integrated PR-AUCs for each fold are shown in Figure 11. All methods had higher in-
tegrated PR-AUC than a random classifier across all cross validation folds. CARS score genetic
marker selection resulted in similiar preditive performance compared to genetic marker selection
by Cox scores. Both approaches were fairly robust against the choice of the threshold α1. Ac-
cording to Figure 11, there appears to be no predictive benefit when genetic markers are added
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to the clinical baseline formula, with CARS scores and Cox scores producing consistent results.
This agrees with the findings in the original publication by Sboner and others (2010).
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Fig. 11. Analysis of the Swedish Watchful Waiting Cohort: The boxplots show the integrated PR-AUCs
of Cox models, as obtained from ten times repeated ten-fold cross-validation. In addition to the clinical
baseline fomula by Sboner and others (2010), the models contained genetic markers that were selected
by CARS and Cox scores. The values {0.01, 0.05, 0.1} represent different q-values cut-off thresholds. The
dashed line denotes the average time integrated event rate and corresponds to the performance of a
random classifier.
The complete data analysis with univariate CARS score screening resulted in 0, 3, and 10
identified genetic markers at the q-value thresholds α1 = {0.01, 0.05, 0.1}, respectively (see ap-
pendix Table C.1). Genetic marker selection by Cox scores yielded 1, 1 and 2 genetic markers at
the same thresholds. Some of the selected genes by CARS scores with α1 = 0.1 match previous
results from the literature: According to the NCBI database (NCBI, 2017), the BIRC5 baculovi-
ral IAP repeat containing 5 is an inhibitor of apoptosis and found in most tumor cells. The gene
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BMX non-receptor tyrosine kinase regulates differentiation and tumorigenicity of several types of
cancer cells, and another gene (MLLT11, transcription factor 7 cofactor) was expressed in several
leukemic cell lines. The complete list of identified genes with CARS scores is available in the
appendix (Table C.1).
3.7 Application to breast cancer microarray data
In our second real-world example we applied CARS and Cox scores to an invasive breast cancer
data set collected by Hatzis and others (2011); Itoh and others (2014). Merging both available
microarray gene expression data sets in the NCBI database (Edgar and others, 2002, GEO ac-
cession numbers GSE25055, GSE25065 and series GSE25066 ) resulted in 502 observations and
22338 variables. These can be partioned into 55 clinical variables, metadata variables and 22283
gene expression markers. The data was collected using GPL96 [HG-U133A] Affymetrix Human
Genome U133A Arrays. The outcome was the time to distant relapse-free survival before surgery
(median = 2.716 years, range = [0, 7.439] years. 21.91% of the patients had a relapse within
the study duration. The 2.5% and 97.5% quantiles of the Pearson correlations between the gene
expressions were [−0.2467, 0.2725] and the maximum absolute correlation was 0.9986.
Analogous to the previous subsection, we used ten times repeated ten-fold cross-validation to
analyze predictive performance. The clinical baseline model included the covariates age, tumor
stage and an indicator of estrogen receptor (ER) positiveness. The genetic markers were selected
by either CARS or Cox scores with different q-value thresholds α1 = {0.01, 0.05, 0.1}. The sig-
nificant genetic markers were added to the clinical covariates, and a Cox regression model was
fitted. Due to the large number of covariates, Cox regression was regularized with an L1 penalty.
The regularization parameter was tuned by internal 10-fold cross-validation as implemented in
the R package glmnet.
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The predictive performance of Cox regression based on CARS and Cox scores is shown in
Figure 12. It is seen that CARS scores performed better than Cox scores for all levels of α1. For
example, when using α1 = 0.01 as significance threshold, 22 out of the 22283 genetic markers were
selected by the CARS-based procedure. Genetic marker selection based on Cox scores identified
zero genetic markers at α1 = 0.01 and failed to include influential genetic markers, which de-
graded predictive performance. In contrast to the data Swedish Watchful Waiting Cohort, there
were notable improvements in predictive performance when the genetic markers were added to
the clinical model. All identified genes are presented in the appendix (Table C.1).
In order to annotate the 22 genes indicated by the CARS score as highly associated with
survival at a q-value level α1 < 0.01 we conducted a gene set enrichment analysis based on
gene ontology (GO) (Consortium, 2001) terms as implemented in the Bioconductor (Huber and
others, 2015) package topGO (Alexa and others, 2006). The GO framework provides a set of
structured vocabularies for specific biological domains that can be used to describe gene products
in any organism. We computed Fisher’s test for enrichment of molecular function and report
in supplementary Table C.2 the 32 GO terms that were enriched at p-value significance level
α2 < 0.05. Among the five GO terms that had attained α2 < 0.01 in the Fisher enrichment test,
we detected both protein-glycine ligase activity and protein-glycine ligase activity inhibition.
Glycine metabolism has been associated with cancer cell proliferation (Amelio and others, 2014),
and glycine uptake and catabolism can promote tumourigenesis and malignancy (Jain and others,
2012). The third enriched GO term was Ras guanyl-nucleotide exchange factor activity. Guanyl-
nucleotide exchange factors are proteins that activate GTPases, which are enzymes binding and
hydrolizing guanosine triphosphate. Ras is one of the key oncogenes; altough Ras mutations
are comparatively rare in breast cancer, the RasGAP (Ras GTPase Activating Proteins) gene
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Fig. 12. Analysis of the breast cancer data by Hatzis and others (2011): The boxplots show the integrated
PR-AUCs of L1-penalized Cox models, as obtained from ten-times repeated ten-fold cross-validation. In
addition to the clinical baseline fomula, the models contained genetic markers that were selected by CARS
and Cox scores. The average time integrated event rate is displayed as a dashed line, which corresponds
to the performance of a random classifier.
RASAL2 functions as tumour suppressor (McLaughlin and others, 2013). Furthermore we found
enrichment evidence for sodium bicarbonate symporter activity, which enables the transfer of a
solute or solutes from one side of a membrane to the other and has a central roles in pH regulation.
Solid tumour exhibit different pH profiles compared to normal tissues, which points at a metabolic
shift towards acid-producing pathways, reflecting both oncogenic signalling and the development
of hypoxia (Gorbatenko and others, 2014). The sodium bicarbonate cotransporter NBCn1 is
the predominant mechanism of acid extrusion in primary breast carcinomas compared to normal
tissues (Boedtkjer and others, 2013) affecting intracellular pH levels. Finally we detected evidence
of estrogen 16-alpha-hydroxylase activity, which is one of the earliest reported biomarkers for
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breast cancer (Bradlow and others, 1986).
4. Summary and discussion
With high-dimensional omics data becoming more readily available in medical research, fast and
efficient screening methods are needed for statistical model building and prediction. In this pa-
per, we developed a framework for the selection of genetic markers in time-to-event models. This
framework helps to improve biomarker discovery especially in high-dimensional settings with a
large number of candidate variables. The proposed CARS score, which evaluates the associations
between the de-correlated marker values and the time-to-event outcome, is estimated consistently
by combining a set of IPC-weighted variance-covariance estimates. As shown in Section 2, esti-
mates can be computed efficiently even when the number of candidate markers is large. Based
on the rankings of the CARS score estimates, genetic markers can be selected for inclusion in a
multivariable time-to-event model, where selection errors can be controlled by the adaptive false
discovery rate density approach of Strimmer (2008).
In the numerical experiments presented in Section 3, CARS scores showed promising results
with regard to the identification of influential marker variables. In particular, screening based
on CARS scores outperformed tradional screening methods based on Cox scores in most of the
analyzed scenarios. The proposed methodology resulted in increased PR-AUC values, and also
in higher correlations between the rankings of the estimated and the true marker effects. With
regard to predictive performance, the difference between CARS and Cox scores became largest
when marker correlations were high. In these situations, the de-correlation of the markers – which
is the key feature of CARS scores – had a particularly strong effect on the predictive performance
of the multivariable models. Conversely, Cox-based screening – which ignores the correlations
between markers – could not discriminate between noise and influential variables in low and high
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covariate correlation settings, thereby degrading predictive performance. Since IPC-weighted es-
timators tend to be have a high variance when censoring rates are high, we also evaluated the
proposed estimators in scenarios with censoring rates as high as 75%. Even in these extreme
cases, CARS-based screening did not result in a systematically worse performance than Cox-
based screening. Furthermore the CARS scores are computationally efficient in high dimensional
settings due to exploiting advanced matrix decompositions.
CARS scores are based on the theoretical framework of parametric accelerated failure time
models. Future research could investigate how to extend this framework to semiparametric and/or
nonlinear regression and different censoring mechanisms.
5. Software
All methods were implemented in R (R Core Team, 2017) and published as add-on package
carSurv (Version 1.0.0), which is available from CRAN. Other packages used in this article include
survival (Version 2.41-3) (Therneau, 2015), fdrtool (Version 1.2.15) (Klaus and Strimmer, 2015),
survAUC (Version 1.0-5) (Potapov and others, 2012), ggplot2 (Version 2.2.1) (Wickham, 2009),
mvnfast (Fasiolo, 2016), PRROC (Version 1.3) (Grau and others, 2015) and glmnet (Version
2.0-13) (Simon and others, 2011).
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APPENDIX
A. Proof of consistency of CAR survival scores
This section proofs that the the CAR survival score θˆ is consistent for θ. CARS scores and their
components are defined in the Equations A.1 to A.6. The proof is partitioned into four parts:
Second the consistency of the weighted sample variance s2Y ;w of the response is evaluated in the
next Section A.2. Third the consistency of the weighted response sample covariance sXj ,Y ;w is
analysed (Section A.3). In the last part the consistency of θˆ is derived in Section A.4 by combining
all previous parts together.
θˆ = R
−1/2
X RX,Y (A.1)
RX,Y =
 sXj ,Y ;w√
s2Xj
√
s2Y ;w

j=1,...,d
(A.2)
sXj ,Y ;w =
1
n
n∑
i=1
wi(xij − x¯j)
(
log(t˜i)− y¯w
)
(A.3)
s2Xj =
1
n− 1
n∑
i=1
(xi,j − x¯j)2 (A.4)
s2Y ;w =
1
n
n∑
i=1
wi
(
log(t˜i)− y¯w
)2
(A.5)
y¯w =
1
n
n∑
i=1
wi log(t˜i) (A.6)
A.1 Consistency of IPC weighted mean
To show the consistency of y¯w it is sufficient to embed this estimator into the framework of
unbiased estimation equations (Huber, 1967). A weighted version of the unbiased estimation
equations is used to account for censoring, which was developed in the context of nonresponse
sample survey theory (Thompson, 1997; Skinner and Mason, 2012). In this context the unbiased
estimating equation for parameter Θ is given by
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1
n
n∑
i=1
ψ(Y˜i, wi,Θ) = 0 (A.7)
E
(
ψ(Y˜i, wi,Θ)
)
= 0 ∀i = 1, . . . , n (A.8)
wi =
I(Ci > Ti)
Gˆn(log(T˜i))
(A.9)
Gˆn(y) =
∏
j:log(t˜i)6y
(
1− ej
rj
)
(A.10)
Under some regularity conditions given in Huber (1967) (e. g. measureability, continuity and
uniqueness of solutions) the estimator of Θˆ is consistent for Θ if Equation A.8 holds. The weights
wi are inverse probability censoring adjustments based on the ideas of the Horvitz Thompson
estimator (Horvitz and Thompson, 1952). Each observation i = 1, . . . , n of the data contains
the observed time response, event indicator and covariates
(
yi = log(t˜i),∆i,xi
)
. The estimate of
the logarithmic censoring survivor function Gˆn(log(t)) corresponds to the Kaplan-Meier product
estimator (Kaplan and Meier, 1958) with individuals at risk rj just prior the actual log(t) and
number of observed events ej . The Kaplan-Meier product estimator is consistent and therefore
the empirical estimate can be replaced by the true survival function in asymptotic analysis. From
now on assume that G(y) is known, G(y) > ν > 0 with a small real number ν, Ti > 0;Ci > 0
and independence of survival and censoring times. Next consider the estimation equation for the
weighted mean y¯w:
ψ(Y˜i, wi, µlog(T )) = wi log(t˜i)− µlog(T ) (A.11)
E
(
wi log(t˜i)
)
=
∞∫
−∞
∞∫
−∞
I (log(Ci) > log(Ti))
G(log(T˜i))
log(T˜i)flog(T ) (log(T ))
flog(C) (log(C)) d log(T ) d log(C) (A.12)
The indicator function I (log(Ci) > log(Ti)) states that only observed survival times con-
tribute to ψ(Y˜i, wi, µT ) and therefore T˜i can be replaced by Ti. The next steps following Equation
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A.13 show that y¯w is unbiased for the parameter µlog(T ). It follows under regularity conditions
that y¯w is a consistent estimator of µlog(T ):
E
(
wi log(t˜i)
)
=
∞∫
−∞
1
G(log(Ti))
log(Ti)flog(T ) (log(T ))
∞∫
log(ti)
flog(C) (log(C)) d log(T ) d log(C) (A.13)
=
∞∫
−∞
G (log(Ti))
G(log(Ti))
log(Ti)flog(T ) (log(T )) d log(T ) (A.14)
= µlog(T ) (A.15)
A.2 Consistency of IPC weighted variance
The unbiasedness of y¯w with respect to µlog(T ) allows to replace y¯w in the weighted variance
estimator s2Y ;w by the true value µlog(T ) in asymptotic analysis. The ψ transformation for the
weighted variance estimator s2Y ;w is given by
ψ
(
Y˜i, wi, σ
2
log(T )
)
= wi
(
log(Ti)− µlog(T )
)2 − σ2log(T ) (A.16)
= wi log(Ti)
2 − 2wi log(Ti)µlog(T ) + wiµ2log(T ) − σ2log(T ) (A.17)
The expectation of the weights wi equal one and therefore the two middle terms of Equation
A.17 cancel each other out:
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E (wi) =
∞∫
−∞
∞∫
−∞
I (log(Ci) > log(Ti))
G(log(T˜i))
flog(T ) (log(T )) flog(C) (log(C)) d log(T ) d log(C) (A.18)
=
∞∫
−∞
1
G(log(Ti))
flog(T ) (log(T ))
∞∫
log(ti)
flog(C) (log(C)) d log(T ) d log(C) (A.19)
=
∞∫
0
G (log(Ti))
G(log(Ti))
flog(T ) (log(T )) d log(T ) = 1 (A.20)
⇒ E
(
wi
(
log(Ti)− µlog(T )
)2)
= E(wi log(Ti)
2)− µ2log(T ) (A.21)
The remaining stochastic term wi log(Ti)
2 is further evaluated. Using the same reasoning as in
Section A.1 the expectation yields unbiasedness of the estimating equation 1n
∑n
i=1 ψ
(
Y˜i, wi, σ
2
log(T )
)
for σ2log(T ) (see Equations A.22 to A.26). Therefore the estimator s
2
Y ;w is consistent for σ
2
log(T ).
E(wi log(Ti)
2) =
∞∫
−∞
∞∫
−∞
I (log(Ci) > log(Ti))
G(log(T˜i))
log(Ti)
2flog(T ) (log(T ))
flog(C) (log(C)) d log(T ) d log(C) (A.22)
=
∞∫
−∞
1
G(log(Ti))
log(Ti)
2flog(T ) (log(T ))
∞∫
log(ti)
flog(C) (log(C)) d log(T ) d log(C) (A.23)
=
∞∫
−∞
log(Ti)
2flog(T ) (log(T )) d log(T ) (A.24)
= σ2log(T ) + µ
2
log(T ) (A.25)
⇒ E
(
ψ(Y˜i, wi, σ
2
log(T ))
)
= 0 (A.26)
A.3 Consistency of IPC weighted covariance
Following the same strategy as in the previous Section A.2 the estimating equation is adapted to
the sample covariance estimator sXj ,Y ;w:
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ψ
(
Y˜i, wi, σXj ,log(T )
)
= wi(xij − µj)
(
log(t˜i)− µlog(T )
)− σXj ,log(T ) (A.27)
= wixij log(t˜i)︸ ︷︷ ︸
F
−wixijµlog(T )︸ ︷︷ ︸
G
−wiµj log(t˜i)︸ ︷︷ ︸
H
+wiµjµlog(T ) − σXj ,log(T ) (A.28)
The order of multiple Riemann integrals can be switched without changing the final result
(Elstrodt, 2011). The analysis of the expectations F,G,H yields
E(F ) =
∞∫
−∞
∞∫
−∞
∞∫
−∞
I (log(Ci) > log(Ti))
G(log(T˜i))
log(T˜i)Xi,jflog(T ),Xj (log(T ), Xj)
flog(C) (log(C)) d log(T ) dXj d log(C) (A.29)
=
∞∫
−∞
∞∫
−∞
log(Ti)Xi,jflog(T ),Xj (log(T ), Xj) d log(T ) dXj = σXj ,log(T ) + µjµlog(T ) (A.30)
E(G) = µlog(T )
∞∫
−∞
∞∫
−∞
∞∫
−∞
I (log(Ci) > log(Ti))
G(log(T˜i))
Xi,jfXj ,log(T ) (Xj , log(T ))
flog(C) (log(C)) dXj d log(T ) d log(C) (A.31)
= µlog(T )
∞∫
−∞
Xj
∞∫
−∞
fXj ,log(T ) (Xj , log(T )) dXj d log(T ) (A.32)
= µlog(T )
∞∫
−∞
XjfXj (Xj) dXj = µjµlog(T ) (A.33)
E(H) = µj
∞∫
−∞
∞∫
−∞
I (log(Ci) > log(Ti))
G(log(T˜i))
log(T˜i)flog(T ) (log(T ))
flog(C) (log(C)) d log(T ) d log(C) (A.34)
= µj
∞∫
−∞
log(Ti)flog(T ) (log(T )) d log(T ) = µjµlog(T ) (A.35)
Combining the results F,G,H with the other terms of the Equation A.28 shows the unbi-
asedness of ψ
(
Y˜i, wi, σXj ,log(T )
)
for the parameter σXj ,log(T ). The consistency follows from the
theory of unbiased estimating equations (Huber, 1967):
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E(G) = E(H) (A.36)
E
(
ψ
(
Y˜i, wi, σXj ,log(T )
))
= E(F )− E(G)− E(H) + µjµlog(T ) − σXj ,log(T ) (A.37)
= 0 (A.38)
A.4 Combination of proof results
In this section all previous consistency proofs of weighted mean, weighted variance and weighted
covariance are combined together to the CARS score. If PX,Y are the true pairwise correlations
between the covariates and the response, it follows that
lim
n→∞RX,Y = limn→∞
(
sY,Xj ;w
sXjsY ;w
)
j=1,...,d
−→ PX,Y (A.39)
is consistent too, because product and quotient transformations of three consistent estima-
tors are likewise consistent (Lehmann, 1998). Another part of the CARS score is the shrinkage
estimator RShrink of the correlations between the covariates RX (Scha¨fer and Strimmer, 2005)
RShrink = λIp + (1− λ)RX (A.40)
λˆ =
∑
j 6=k V̂ ar(rˆj,k)∑
j 6=k rˆ
2
j,k
(A.41)
rˆj,k =
1
n−1
∑n
i=1 (xi,j − x¯j) (xi,k − x¯k)√
1
n−1
∑n
i=1 (xi,j − x¯j)2
√
1
n−1
∑n
i=1 (xi,k − x¯k)2
(A.42)
The shrinkage parameter λ is estimated as well. Ip ∈ Zp×p is the unit matrix. rˆj,k are the
sample correlations between the j-th and k-th variables. In the limit the estimator converges to
zero:
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lim
n→∞ λˆ =
limn→∞
∑
j 6=k V̂ ar(rˆj,k)
limn→∞
∑
j 6=k rˆ
2
j,k
(A.43)
=
∑
j 6=k limn→∞ V̂ ar(rˆj,k)∑
j 6=k limn→∞ rˆ
2
j,k
(A.44)
=
∑
j 6=k 0∑
j 6=k r
2
j,k
= 0 (A.45)
⇒ lim
n→∞ λˆ = 0 (A.46)
Because rˆj,k is a consistent estimator of rj,k, the variance of this estimator V̂ ar(rˆj,k) must con-
verge to zero. Subsequent the shrinkage parameter converges to zero. If λ = 0, thenRShrink = RX
which is itself a consistent estimator of the covariates correlation matrix PX . Further the in-
verse square root R
−1/2
shrink of the shrinkage estimator is consistent too, because the transfor-
mation function is continuous. Combining all previous results shows the consistency of CARS
θˆ = R
−1/2
shrinkRX,Y for θ, because it is a product of two consistent estimators.
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B. Additional results obtained from the simulation study
B.1 CARS simulation with low absolute covariate correlations
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Fig. 13. Simulation study – scenario with low absolute correlations (ρ = ±0.25): The boxplots visualize
the PR-AUC values obtained from variable selection by CARS scores, Cox scores and L1-penalized Cox
regression. The censoring rate was equal to 0.25. The average prevalance of the positive class (computed
from all simulations) is displayed by a dashed line. Note that the boxplots contain the PR-AUC values
corresponding to all three rates of influential covariates (1%, 5%, 10%). Each boxplot shows the results of
24300 simulation runs (3 explained variance ratios x 3 signal to noise ratios x 3 sample sizes x 3 number
of covariates x 300 repetitions).
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B.2 CARS simulation with high absolute covariate correlations
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
ll
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
ll
l
l
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
l
0.0
0.1
0.2
0.3
0.4
0.5
0.6
CARS Cox Cox L1
Method
PR
−A
UC
Fig. 14. Simulation study – scenario with high absolute correlations (ρ = ±0.75): The boxplots visualize
the PR-AUC values obtained from variable selection by CARS scores, Cox scores and L1-penalized Cox
regression. The censoring rate was equal to 0.25. The average prevalance of the positive class (computed
from all simulations) is displayed by a dashed line. Note that the boxplots contain the PR-AUC values
corresponding to all three rates of influential covariates (1%, 5%, 10%). Each boxplot shows the results of
24300 simulation runs (3 explained variance ratios x 3 signal to noise ratios x 3 sample sizes x 3 number
of covariates x 300 repetitions). Cox scores interquartile range is below PR-AUC of a random classifier.
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B.3 CARS simulation with high absolute covariate correlations and censoring rate
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Fig. 15. Simulation study – scenario with high absolute correlations (ρ = ±0.75) and a high censoring rate
of 0.75: The boxplots visualize the PR-AUC values obtained from variable selection by CARS scores,
Cox scores and L1-penalized Cox regression. The average prevalance of the positive class (computed
from all simulations) is displayed by a dashed line. Note that the boxplots contain the PR-AUC values
corresponding to all three rates of influential covariates (1%, 5%, 10%). Each boxplot shows the results of
24300 simulation runs (3 explained variance ratios x 3 signal to noise ratios x 3 sample sizes x 3 number
of covariates x 300 repetitions). Cox scores interquartile range is below PR-AUC of a random classifier.
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B.4 Construction of correlation matrix
In this section give more details for the construction of the correlation matrices used in the
simulation (see Section 3.1). First a preparatory design matrix A is created. A is partitioned in
three blocks of equal size. The correlations between covariates cover a small range in the first
block, medium range in the second block and a larger range in the third block. Within each block,
half of all correlations are positive and the other half is negative. For example consider the case
with 12 covariates: Then each design block would be given by the matrix
A =

1 ξ ξ −ξ
ξ 1 ξ −ξ
ξ ξ 1 −ξ
−ξ −ξ −ξ 1
 (B.1)
with ξ = {0.25, 0.5, 0.75} in the corresponding blocks. All correlations between variables be-
longing to different blocks are set to zero. Then the prepared matrix is converted to the nearest
possible positive definite matrix B, measured by a weighted Frobenius Norm ‖B‖W of the ele-
mentwise differences between the specified and new matrix:
Ω (B) = min {‖A−B‖W : B is a correlation matrix} (B.2)
‖B‖W = ‖W ◦B‖F ; W symmetric and positive (B.3)
‖B‖2F =
∑
i,j
b2i,j (B.4)
Here ◦ denotes the Hadamard product (elementwise matrix multiplication) and bi,j are the
elements of matrix B. For further details of the algorithm to minimize the deviations Ω (B) from
A we refere to Higham (2002). A histogram with relative frequencies of the correlation matrix
entries, after applying the algorithm, above the diagonal based on 1000 covariates are shown in
the next figure:
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Fig. 16. The top figure shows the histogram (100 equal sized intervals) of the first block of the final
correlation matrix with 1000 covariates. Only correlations above the diagonal are shown. Middle figure
shows the histogram of the second block and the lower figure gives the relative frequencies of the third
block.
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C. Additional material used for the data analysis
C.1 CARS scores: Selected variables in data analysis
Gene symbol CARS score Q-value
NM 007244 0.1063 0.0461
NM 004912 -0.1035 0.0461
NM 203281 -0.1016 0.0461
NM 001012271 -0.0944 0.0814
NM 021992 -0.0939 0.0835
NM 006818 0.0939 0.0836
NM 005722 -0.0928 0.0877
NM 003855 -0.0923 0.0895
NM 001186 -0.0916 0.0918
NM 006846 0.0906 0.0965
Table 1. Prostate cancer: CARS scores and q-values below α = 0.1 ordered by absolute score magnitude.
Gene symbol refers to the accession number in the NCBI database (Edgar and others, 2002).
Gene Symbol CARS score Q-value
GRIN2C -0.0479 1.0560 ∗ 10−6
RGP1 0.0446 6.8075 ∗ 10−6
TSPAN5 0.0446 6.8776 ∗ 10−6
RGS12 0.0441 7.7700 ∗ 10−6
ITGA2B 0.0404 1.1334 ∗ 10−4
SURF1 -0.0402 1.3162 ∗ 10−4
ZC2HC1A 0.0386 3.7071 ∗ 10−4
MCM9 0.0369 1.0399 ∗ 10−3
TRRAP 0.0368 1.0732 ∗ 10−3
SLC4A5 0.0360 1.7160 ∗ 10−3
FEZ2 -0.0356 2.1184 ∗ 10−3
ARPC4 /// ARPC4-TTLL3 /// TTLL3 0.0347 3.2360 ∗ 10−3
KERA 0.0347 3.3192 ∗ 10−3
GPR98 0.0341 4.4523 ∗ 10−3
SEPT6 0.0336 5.6147 ∗ 10−3
PRUNE2 0.0334 6.1200 ∗ 10−3
PLEKHG3 0.0332 6.6953 ∗ 10−3
AW9738341 0.0329 7.4615 ∗ 10−3
CYP2C8 0.0326 8.2900 ∗ 10−3
CUZD1 0.0326 8.4730 ∗ 10−3
CTSF 0.0324 8.8681 ∗ 10−3
KIAA0485 0.0323 9.0860 ∗ 10−3
Table 2. Breast cancer: CARS scores and q-values below α = 0.01 ordered by absolute score magnitude.
Gene symbol refers to the accession number in the NCBI database (Edgar and others, 2002) or proteins.
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C.2 Summary of gene enrichment analysis
GO.ID Term Ann Signif Expect p-value
GO:0070735 Protein-glycine ligase activity 2 1 0 0.0020
GO:0070736 Protein-glycine ligase activity 2 1 0 0.0020
GO:0005088 Ras guanyl-nucleotide exchange factor 373 3 0.35 0.0057
GO:0008510 Sodium:bicarbonate symporter activity 10 1 0.01 0.0099
GO:0101020 Estrogen 16-alpha-hydroxylase activity 10 1 0.01 0.0099
GO:0005085 Guanyl-nucleotide exchange factor activity 470 3 0.44 0.0107
GO:0004972 NMDA glutamate receptor activity 13 1 0.01 0.0128
GO:0070051 Fibrinogen binding 13 1 0.01 0.0128
GO:0033695 Oxidoreductase activity acting on CH 15 1 0.01 0.0148
GO:0034875 Caffeine oxidase activity 15 1 0.01 0.0148
GO:0016881 Acid-amino acid ligase activity 21 1 0.02 0.0207
GO:0005452 Inorganic anion exchanger activity 22 1 0.02 0.0217
GO:0015106 Bicarbonate transmembrane transporter activity 23 1 0.02 0.0226
GO:0016725 Oxidoreductase activity, acting on CH 23 1 0.02 0.0226
GO:0015301 Anion:anion antiporter activity 26 1 0.02 0.0255
GO:0004970 Ionotropic glutamate receptor activity 29 1 0.03 0.0284
GO:0005234 Extracellular-glutamate-gated ion channel 30 1 0.03 0.0294
GO:0008324 Cation transmembrane transporter activity 703 3 0.66 0.0309
GO:0004129 Cytochrome-c oxidase activity 33 1 0.03 0.0323
GO:0015002 Heme-copper terminal oxidase activity 33 1 0.03 0.0323
GO:0016676 Oxidoreductase activity 33 1 0.03 0.0323
GO:0008391 Arachidonic acid monooxygenase activity 34 1 0.03 0.0333
GO:0008392 Arachidonic acid epoxygenase activity 34 1 0.03 0.0333
GO:0016675 Oxidoreductase activity 34 1 0.03 0.0333
GO:0070330 Aromatase activity 34 1 0.03 0.0333
GO:0017112 Rab guanyl-nucleotide exchange factor activity 39 1 0.04 0.0381
GO:0008066 Glutamate receptor activity 42 1 0.04 0.0409
GO:0016712 Oxidoreductase activity 42 1 0.04 0.0409
GO:0022824 Transmitter-gated ion channel activity 44 1 0.04 0.0429
GO:0022835 Transmitter-gated channel activity 44 1 0.04 0.0429
GO:0015296 Anion:cation symporter activity 46 1 0.04 0.0448
GO:0008395 Steroid hydroxylase activity 50 1 0.05 0.0486
Table 3. Breast cancer: Gene enrichment analyis based on Fisher’s test with R package topGO. The
first column gives the gene ontology (GO) (Consortium, 2001) identification number and column ”Term”
gives additional details. The number in column ”Ann” shows how many genes are annotated with the
GO term. Column ”Signif” gives the number of significant genes of the GO term with respect to q-value
0.05. ”Expect” shows the expected number of significant genes under the null hypothesis, e.g. no genes
are enriched. The last column ”p-value” gives the p-value for Fisher’s test for enrichment.
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C.3 CARS scores diagnostic plots
Type of Statistic: Correlation (kappa = 1726.7, eta0 = 0.971)
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Fig. 17. Prostate Cancer model diagnostic plots of CARS scores: Density of empirical null model, cu-
mulative distribution function and local FDR. The first two plots show that the mixture models fits the
empirical distribution well.
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Type of Statistic: Correlation (kappa = 18802.8, eta0 = 0.9751)
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Fig. 18. Breast Cancer model diagnostic plots of CARS scores: Density of empirical null model, cumulative
distribution function and local FDR. The first two plots show that the mixture models fits the empirical
distribution well.
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